Émeline Meriaux
Centre François Baclesse(LU)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research, Ovarian cancer diagnosis and treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program(2020)52 cited
- → The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program(2021)24 cited
- → Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)(2020)20 cited
- → Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study(2018)20 cited
- → TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma(2022)11 cited
- → Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study(2023)11 cited
- → Cancer de la prostate : effets secondaires des traitements sur la masculinité (identité masculine, fertilité, sexualité)(2017)4 cited
- → 732P Cabozantinib in non-clear cell metastatic renal cell carcinoma and sarcomatoid renal cell carcinoma: Real-world data from the CABOREAL study(2020)4 cited
- → CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure(2021)4 cited
- → 722P Cabozantinib in elderly patients: Results from a subanalysis of the CABOREAL study(2020)4 cited